An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-γ and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis

European Journal of Immunology

Volumn 34, Issue 2, 2004, Pages 388-397

  Ford, Mandy L ^a   Evavold, Brian D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; CD4+ T cells; EAE; Optic neuritis; Peptides

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN 35-55; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; GLYCOPROTEIN; HISTOCOMPATIBILITY ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE; PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOLOGY; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; OPTIC NERVE DISEASE; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SYMPTOMATOLOGY; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIVISION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; OPTIC NEURITIS; PATHOLOGY; SPINAL CORD;

ANIMALS; AUTOANTIBODIES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; OPTIC NEURITIS; PEPTIDE FRAGMENTS; PEPTIDES; SPINAL CORD;

EID: 1642312993     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324502     Document Type: Article

References (45)

1. Steinman, L., Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996. 85: 299-302.
2. Martin, R., McFarland, H. F. and McFarlin, D. E., Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 1992. 10: 153-187.
3. Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E. and Nicholson, L. B., T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 2002. 20: 101-123.
4. Bernard, C. C., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J. and Bettadapura, J., Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 1997. 75: 77-88.
5. Mendel, I., Kerlero de Rosbo, N. and Ben-Nun, A., A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995. 25: 1951-1959.
6. Soderstrom, M., Ya-Ping, J., Hillert, J. and Link, H., Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 1998. 50: 708-714.
7. Ghezzi, A., Martinelli, V., Torri, V., Zaffaroni, M., Rodegher, M., Comi, G., Zibetti, A. and Canal, N., Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 1999. 246: 770-775.
8. Hu, P., Pollard, J., Hunt, N., Taylor, J. and Chan-Ling, T., Microvascular and cellular responses in the optic nerve of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol. 1998. 8: 475-486.
9. O'Neill, J. K., Baker, D., Morris, M. M., Gschmeissner, S. E., Jenkins, H. G., Butt, A. M., Kirvell, S. L. and Amor, S., Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease. J. Neuroimmunol. 1998. 82: 210-218.
10. Raine, C. S., Traugott, U., Nussenblatt, R. B. and Stone, S. H., Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Lab. Invest. 1980. 42: 327-335.
11. Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A. and Kuchroo, V. K., Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003. 197: 1073-1081.
12. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
13. Evavold, B. D., Sloan-Lancaster, J. and Allen, P. M., Tickling the TCR: selective T cell functions stimulated by altered peptide ligands. Immunol. Today 1993. 14: 602-609.
14. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. and McDevitt, H. O., Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 1989. 59: 247-255.
15. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H., Sette, A. and Hafler, D. A., Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 1995. 2: 373-380.
16. Evavold, B. D. and Allen, P. M., Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991. 252: 1308-1310.
17. Evavold, B. D., Sloan-Lancaster, J., Hsu, B. L. and Allen, P. M., Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 1993. 150: 3131-3140.
18. Nicholson, L. B., Murtaza, A., Hafler, B. P., Sette, A. and Kuchroo, V. K., A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 1997. 94: 9279-9284.
19. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Fairchild, P. J., Wraith, D. C., O'Garra, A., Fathman, C. G. and Steinman, L., Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 1996. 379: 343-346.
20. Kuchroo, V. K., Greer, J. M., Kaul, D., Ishioka, G., Franco, A., Sette, A., Sobel, R. A. and Lees, M. B., A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 1994. 153: 3326-3336.
21. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K., An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995. 2: 397-405.
22. Ford, M. L. and Evavold, B. D., Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of MOG 35-55. J. Immunol. 2003. 171: 1247-1254.
23. Anderton, S. M., Manickasingham, S. P., Burkhart, C., Luckcuck, T. A., Holland, S. J., Lamont, A. G. and Wraith, D. C., Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J. Immunol. 1998. 161: 3357-3364.
24. Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P. and Steinman, L., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 2000. 6: 1176-1182.
25. Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., McFarland, H. F. and Martin, R., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 2000. 6: 1167-1175.
26. Anderton, S. M., Kissler, S., Lamont, A. G. and Wraith, D. C., Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells. Eur. J. Immunol. 1999. 29: 1850-1857.
27. Appleman, L. J., Tzachanis, D., Grader-Beck, T., van Puijenbroek, A. A. and Boussiotis, V. A., Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J. Mol. Med. 2001. 78: 673-683.
28. Schwartz, R. H., Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 1996. 184: 1-8.
29. Zang, Y. C., Samanta, A. K., Halder, J. B., Hong, J., Tejada-Simon, M. V., Rivera, V. M. and Zhang, J. Z., Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain 2000. 123: 1874-1882.
30. Begolka, W. S. and Miller, S. D., Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res. Immunol. 1998. 149: 771-781; discussion 843-774, 855-760.
31. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. G., Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 5-7.
32. Chu, C. Q., Wittmer, S. and Dalton, D. K., Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000. 192: 123-128.
33. Ravetch, J. V. and Bolland, S., IgG Fc receptors. Annu. Rev. Immunol. 2001. 19: 275-290.
34. Robbie-Ryan, M., Tanzola, M. B., Secor, V. H. and Brown, M. A., Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 2003. 170: 1630-1634.
35. Svensson, L., Abdul-Majid, K. B., Bauer, J., Lassmann, H., Harris, R. A. and Holmdahl, R., A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 2002. 32: 1939-1946.
36. Hjelmstrom, P., Juedes, A. E., Fjell, J. and Ruddle, N. H., B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 1998. 161: 4480-4483.
37. Lyons, J. A., San, M., Happ, M. P. and Cross, A. H., B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999. 29: 3432-3439.
38. Kerlero de Rosbo, N., Honegger, P., Lassmann, H. and Metthieu, J. M., Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 1990. 55: 583-587.
39. Linington, C., Engelhardt, B., Kapocs, G. and Lassman, H., Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 1992. 40: 219-224.
40. Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A. and Sinigaglia, F., Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998. 187: 129-134.
41. Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S. T., Sobel, R. A. and Dorf, M. E., Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 1993. 151: 4371-4382.
42. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A. and O'Connor, P. W., A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2003. 348: 15-23.
43. Onami, T. M., Harrington, L. E., Williams, M. A., Galvan, M., Larsen, C. P., Pearson, T. C., Manjunath, N., Baum, L. G., Pearce, B. D. and Ahmed, R., Dynamic regulation of T cell immunity by CD43. J. Immunol. 2002. 168: 6022-6031.
44. Austrup, F., Vestweber, D., Borges, E., Lohning, M., Brauer, R., Herz, U., Renz, H., Hallmann, R., Scheffold, A., Radbruch, A. and Hamann, A., P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997. 385: 81-83.
45. Ryan, K. R. and Evavold, B. D., Persistence of peptide-induced CD4+ T cell anergy in vitro. J. Exp. Med. 1998. 187: 89-96.